Stocks · Health care · Pharmaceutical Preparations

UroGen Pharma Ltd.

URGN Clue Score39
Israel Fiscal year ends December CIK 0001668243 Results filed 4 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Mark Schoenberg
20 Jan 2023
Chief Medical Officer
Exercised, kept
122,677
$5.00
$613.39K
Ran Nussbaum
21 Oct 2022
Director
Exercised, kept indirect
47,999
$5.94
$285.11K
Arie Belldegrun
14 Sep 2022
Director
Exercised, kept
160,000
$5.00
$800.00K
Arie Belldegrun
31 Aug 2022
Director
Exercised, kept
3,241
$5.00
$16.21K
Ran Nussbaum
16 Jun 2022
Director
Exercised, kept indirect
2,211
$5.00
$11.06K
Ran Nussbaum
6 Jun 2022
Director
Exercised, kept indirect
1,030
$5.00
$5.15K
Ran Nussbaum
25 Mar 2021
Director
Exercised, kept indirect
2,211
$5.00
$11.06K
Ran Nussbaum
24 Mar 2021
Director
Exercised, kept indirect
1,030
$5.00
$5.15K
Arie Belldegrun
24 Mar 2021
Director
Exercised, kept
3,241
$5.00
$16.21K
Arie Belldegrun
27 Mar 2019
Director
Exercised, kept
128,000
$4.02
$514.56K
Fred E Cohen
6 Feb 2019
Director
Exercised, kept
15,000
$16.99
$254.85K

What was left out

Form 4 filings counted 196
Amendments (4/A) skipped 12
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 60
Sales at will 31
Transactions with no price 0
Shares from compensation/vesting 1,178,534
Sales filed before the plan box existed 17
History held since 29 Nov 2017